Related Articles
Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-α activation
miR‑146a improves hepatic lipid and glucose metabolism by targeting MED1
Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein
The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease
Atorvastatin promotes AMPK signaling to protect against high fat diet‑induced non‑alcoholic fatty liver in golden hamsters